Rheumatoid Arthritis: In Depth (2022)

Rheumatoid Arthritis: In Depth (1)

What’s the Bottom Line?

  • Medical treatment for rheumatoid arthritis can delay or prevent joint damage—it doesn’t just treat symptoms. The sooner treatment starts, the better. If you have rheumatoid arthritis, follow your health care provider’s instructions on how to treat your condition. If you have joint symptoms that might be caused by rheumatoid arthritis, see your health care provider promptly.

  • To get the best results, don’t substitute other approaches for treatments prescribed or recommended by your health care provider. Consult your provider about adding any complementary health products or practices to your treatment program.

What do we know about the effectiveness of complementary health approaches for rheumatoid arthritis?

  • The amount of research on psychological and/orphysical approaches is too small for conclusions to be reached about whether they can help relieve rheumatoid arthritis symptoms.
  • Supplements containing omega-3 fatty acids, gamma-linolenic acid (GLA), or the herb thunder god vine may help relieve rheumatoid arthritis symptoms.

What do we know about the safety of complementary health approaches for rheumatoid arthritis?

  • The psychological and/or physicalapproaches discussed in this fact sheet generally have good safety records. However, some may need to be adapted to make them safe and comfortable for people with rheumatoid arthritis.

  • Thunder god vine may cause serious side effects, including male infertility and decreases in bone density.

  • The U.S. Food and Drug Administration (FDA) has warned consumers about dietary supplements promoted for arthritis pain that are tainted with prescription drugs.

What Is Rheumatoid Arthritis?

Rheumatoid arthritis (RA) is a disease that causes pain, swelling, and stiffness in the joints. It occurs when the immune system attacks the membrane lining the joints. RA is more common in women than men and often begins in middle age, although it can also occur in younger people.

More About Rheumatoid Arthritis and How It’s Treated
  • RA is an autoimmune disease—a condition in which the immune system attacks the joints for unknown reasons. RA is different from other types of arthritis such as osteoarthritis, a wear-and-tear condition that most commonly occurs as people age.

  • Early treatment to avoid permanent joint damage is key for preventing disability and progression of RA. Treatment for RA combines a variety of approaches and is aimed at relieving pain, reducing inflammation, slowing or stopping joint damage, and improving the person’s sense of well-being and ability to function. Medicines used for RA include disease-modifying antirheumatic drugs (DMARDs) to slow the progress of the disease and nonsteroidal anti-inflammatory drugs (NSAIDs) and corticosteroids to reduce inflammation.

What the Science Says About Complementary Approaches for Rheumatoid Arthritis

Complementary approaches can be classified by their primary therapeutic input (how the therapy is taken in or delivered), which may be:

  • Nutritional (e.g., special diets, dietary supplements, herbs, probiotics, and microbial-based therapies).
  • Psychological (e.g., meditation, hypnosis, music therapies, relaxation therapies).
  • Physical (e.g., acupuncture, massage, spinal manipulation).
  • Combinations such as psychological and physical (e.g., yoga, tai chi, dance therapies, some forms of art therapy) or psychological and nutritional (e.g., mindful eating).

Nutritional approaches include what the National Center for Complementary and Integrative Health (NCCIH) previously categorized as natural products, whereas psychological and/or physical approaches include what was referred to as mind and body practices.

Psychological and Physical Approaches

Acupuncture
  • At least 11 studies of acupuncture for RA, with more than 1,300 total participants, have been completed. These studies have not shown clear evidence of a beneficial effect.
  • Acupuncture is generally considered safe when performed by an experienced practitioner using sterile needles. Improperly performed acupuncture can cause potentially serious side effects.
  • For more information, see the NCCIH webpage on acupuncture.

Massage
  • A single study with 42 participants, conducted in 2013, has indicated that moderate pressure massage therapy may reduce pain and increase grip strength in people who have RA that affects their arms and shoulders.

  • The risk of harmful effects from massage therapy appears to be low. However, there have been rare reports of serious injuries. Some of the reported cases have involved vigorous types of massage, such as deep tissue massage, or patients who might be at increased risk of injury, such as elderly people.

  • For more information, see the NCCIH webpage on massage therapy.

(Video) Rheumatoid arthritis - causes, symptoms, diagnosis, treatment, pathology

Mindfulness Meditation
  • Four studies (401 total participants) have looked at the effects of mindfulness-based interventions in people with RA, and all found evidence of some improvement in subjective symptoms such as pain or in the ability to cope with the illness.

  • Mindfulness meditation may involve staying in one position for a prolonged period of time. This can be difficult or painful for a person with arthritis. If you’re interested in trying mindfulness meditation, tell the instructor about your physical limitations so that the instructor can modify the practice to make it comfortable for you.

  • For more information, see the NCCIH webpage on meditation.

Relaxation Techniques
  • Autogenic training, biofeedback, and other relaxation techniques have been studied in people with RA, but only a small amount of research has been done on each approach. Some results have been promising, but the amount of research is so small that no definite conclusions can be reached.

  • Relaxation techniques generally don’t have side effects. However, rare harmful effects have been reported in people with serious physical or mental health conditions.

  • For more information, visit the NCCIH webpage on relaxation techniques.

Tai Chi

Several studies have looked at the effects of practicing tai chi on people with RA. Some studies showed improvements in participants’ physical functioning, but others did not. Most of these studies are more than 10 years old (some much older than that), so the study participants would not have been taking the types of drugs used in RA treatment today. Because of the inconsistent findings and the changes in RA treatment over the years, it’s uncertain whether tai chi has benefits in RA.

Studies of tai chi for RA indicate that it doesn’t make symptoms worse. However, traditional forms of tai chi may need to be adapted so that people with RA can participate safely and comfortably.

For more information, visit the NCCIH webpage on tai chi.

Yoga
  • Yoga incorporates several elements of exercise that may be beneficial for arthritis, including activities that may help improve strength and flexibility. However, only a few studies have examined yoga for RA, and they have not been of high quality. They haven’t clearly shown whether it’s helpful.

  • Yoga exercises should be performed with caution by people with RA who have limited mobility or spinal problems. People with RA may need assistance in modifying some yoga postures to minimize joint stress and may need to use props to help with balance.

  • For more information, see the NCCIH webpage on yoga.

Nutritional Approaches

(Video) Rheumatoid Arthritis (RA) Signs & Symptoms (& Associated Complications)

Omega-3 Fatty Acids
  • Omega-3 fatty acids are a kind of fat found in foods and in the human body. They are also sold as dietary supplements. Different types of omega-3s are found in different foods. Much research has focused on the long-chain omega-3s found in seafood (fish and shellfish).
  • A 2017 review of 22 studies (956 total participants) that tested supplements of long-chain omega-3s found a favorable effect on pain in patients with RA.
  • Omega-3 supplements usually produce only mild side effects, if any. There’s conflicting evidence on whether omega-3 supplements might influence the risk of prostate cancer. If you’re taking medicine that affects blood clotting or if you’re allergic to fish or shellfish, consult your health care provider before taking omega-3 supplements.
  • For more information, visit the NCCIH webpage on omega-3s.

Gamma-Linolenic Acid (GLA)
  • GLA is an omega-6 fatty acid found in the oils from some plants, including evening primrose (Oenothera biennis), borage (Borago officinalis), and black currant (Ribes nigrum). Oils containing GLA may have some benefit in relieving RA symptoms; however, only a few studies have been conducted on each of the oils.

  • In short-term studies, oils containing GLA produced only mild side effects, such as upset stomach or headache. The long-term safety of GLA supplements is uncertain. Some borage products may contain substances called pyrrolizidine alkaloids that can harm the liver.

Probiotics
  • A few preliminary studies have tested various probiotics in patients with RA, but the types of probiotics used differed from study to study, and the results differed as well. No conclusions about the effects of probiotics can be reached on the basis of the current evidence.

  • In people who are generally healthy, probiotics have a good safety record. Side effects, if they occur at all, usually consist only of mild digestive symptoms such as gas. However, information on the long-term safety of probiotics is limited, and safety may differ from one type of probiotic to another. Probiotics have been linked to severe side effects, such as dangerous infections, in people with serious underlying medical problems.

  • For more information, visit the NCCIH webpage on probiotics.

Thunder God Vine
  • Thunder god vine (Tripterygium wilfordii) is an herb used in traditional Chinese medicine. There have been only a few high-quality studies of oral thunder god vine for RA. These studies indicate that thunder god vine may improve some RA symptoms. In two studies, thunder god vine was at least as helpful as a conventional drug. Promising results have also been seen in studies in China where thunder god vine was used in combination with a conventional drug.

  • Thunder god vine can have serious side effects, including loss of bone density and male infertility. Thunder god vine can be extremely poisonous if the extract is not prepared properly. The risks of using this herb may exceed its benefits.

  • For more information, see the NCCIH webpage on thunder god vine.

Other Dietary Supplements
  • Other dietary supplements that have been studied for RA include cat’s claw, deer or elk antler velvet, feverfew, flaxseed oil, green-lipped mussel, rose hip, and willow bark extract. For all of these supplements, only a very small amount of research has been done in people, and it isn’t possible to reach any conclusions about their effects.

Tainted Arthritis Supplements

The FDA has warned the public about several dietary supplements promoted for arthritis or pain that were tainted with prescription drugs. The hidden ingredients in these products could cause side effects or interact in harmful ways with medicines.

You can find a list oftainted arthritis/pain products and general information about dietary supplements on the FDA website. It’s also a good idea to talk with your health care provider about any dietary supplement you’re taking or considering.

(Video) Rheumatoid Arthritis Nursing NCLEX Lecture: Symptoms, Treatment, Interventions, Medications

Other ComplementaryHealthApproaches

  • Ayurvedic medicine is a system of health care that originated in India. Two preliminary studies (161 total participants) have compared Ayurvedic herbal preparations with conventional drugs used to treat RA. Both indicated that some Ayurvedic preparations may be comparable in effectiveness to the drugs. However, the two studies used different Ayurvedic preparations and compared them with different drugs.

  • Ayurvedic medicine uses a variety of products and practices. Some products may be harmful, particularly if used improperly or without the direction of a trained practitioner.

  • For more information, see the NCCIH webpage on Ayurvedic medicine.

Balneotherapy
  • Balneotherapy is the technique of bathing in tap or mineral water for health purposes; it also includes related practices such as mud packs. A 2016 review of 8 studies of balneotherapy for RA (496 total participants) was unable to reach definite conclusions because of the variability in the types of balneotherapy used in different studies as well as variability in study designs.

  • Balneotherapy has a good safety record.

Special Diets
  • The effects of special diets—such as vegetarian, Mediterranean, or elimination diets—on RA are uncertain because very little research has been done.

  • In studies that tested special diets for RA, some people lost weight even though they didn’t intend to, an effect that is undesirable in people who are already at or below normal weight. Some special diets, especially those that eliminate one or more major food groups, are so restrictive that they may put people at risk of developing nutritional deficiencies.

More To Consider

If you’re considering dietary supplements, keep in mind that they can cause health problems if not used correctly, and some may interact with prescription or nonprescription medications or other dietary supplements. Your health care provider can advise you. If you’re pregnant or nursing a child, or if you’re considering giving a child a dietary supplement, it’s especially important to consult your (or the child’s) health care provider. To learn more, visit the NCCIH webpage on dietary supplements.

Take charge of your health—talk with your health care providers about any complementary health approaches you use. Together, you can make shared, well-informed decisions.

For More Information

NCCIH Clearinghouse

The NCCIH Clearinghouse provides information onNCCIHand complementary and integrative health approaches, including publications and searches of Federal databases of scientific and medical literature. The Clearinghouse does not provide medical advice, treatment recommendations, or referrals to practitioners.

Toll-free in the U.S.: 1-888-644-6226

Telecommunications relay service (TRS): 7-1-1

Website: https://nccih.nih.gov/

Email: info@nccih.nih.gov (link sends email)

(Video) Rheumatoid Arthritis Pathophysiology (signs and symptoms)

Know the Science

NCCIH and the National Institutes of Health (NIH) provide tools to help you understand the basics and terminology of scientific research so you can make well-informed decisions about your health. Know the Science features a variety of materials, including interactive modules, quizzes, and videos, as well as links to informative content from Federal resources designed to help consumers make sense of health information.

Explaining How Research Works (NIH)

Know the Science: 9 Questions To Help You Make Sense of Health Research

Understanding Clinical Studies (NIH)

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

The mission of NIAMS is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; the training of basic and clinical scientists to carry out this research; and the dissemination of information on research progress in thesediseases.

Toll-free in the U.S.: 1-877-22-NIAMS

Website: https://www.niams.nih.gov

PubMed®

A service of the National Library of Medicine, PubMed® contains publication information and (in most cases) brief summaries of articles from scientific and medical journals. For guidance from NCCIH on using PubMed, see How To Find Information About Complementary Health Approaches on PubMed.

Website: https://pubmed.ncbi.nlm.nih.gov/

MedlinePlus

To provide resources that help answer health questions, MedlinePlus (a service of the National Library of Medicine) brings together authoritative information from the National Institutes of Health as well as other Government agencies and health-relatedorganizations.

Website: https://www.medlineplus.gov/

Key References

Other References

  • Anain JM Jr, Bojrab AR, Rhinehart FC. Conservative treatments for rheumatoid arthritis in the foot and ankle. Clinics in Podiatric Medicine and Surgery. 2010;27(2):193-207.
  • Badsha H, Chhabra V, Leibman C, et al. The benefits of yoga for rheumatoid arthritis: results of a preliminary, structured 8-week program. Rheumatology International. 2009;29(12):1417-1421.
  • Bamford JT, Ray S, Musekiwa A, et al. Oral evening primrose oil and borage oil for eczema. Cochrane Database of Systematic Reviews. 2013;(4):CD004416. Accessed at http://www.cochranelibrary.com on January 16, 2018.
  • Bosch PR, Traustadóttir T, Howard P, et al. Functional and physiological effects of yoga in women with rheumatoid arthritis: a pilot study. Alternative Therapies in Health and Medicine. 2009;15(4):24-31.
  • Brasky TM, Darke AK, Song X, et al. Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial. Journal of the National Cancer Institute. 2013;105(15):1132-1141.
  • Bykerk VP, Akhavan P, Hazlewood GS, et al. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs. Journal of Rheumatology. 2012;39(8):1559-1582.
  • Canter PH, Lee HS, Ernst E. A systematic review of randomised clinical trials of Trypterygium wilfordii for rheumatoid arthritis. Phytomedicine. 2006;13(5):371-377.
  • Chang CY, Wu YT, Chen LC, et al. Massage-induced brachial plexus injury. Physical Therapy. 2015;95(1):109-116.
  • Chopra A, Saluja M, Tillu G, et al. Comparable efficacy of standardized Ayurveda formulation and hydroxychloroquine sulfate (HCQS) in the treatment of rheumatoid arthritis (RA): a randomized investigator-blind controlled study. Clinical Rheumatology. 2012;31(2):259-269.
  • Christie A, Jamtvedt G, Dahm KT, et al. Effectiveness of nonpharmacological and nonsurgical interventions for patients with rheumatoid arthritis: an overview of systematic reviews. Physical Therapy. 2007;87(12):1697-1715.
  • Chua ME, Sio MCD, Sorongon MC, et al. Relationship of dietary intake of omega-3 and omega-6 fatty acids with risk of prostate cancer development: a meta-analysis of prospective studies and review of literature. Prostate Cancer. 2012;2012:826254.
  • Cramer H, Lauche R, Langhorst J, et al. Yoga for rheumatic diseases: a systematic review. Rheumatology. 2013;52(11):2025-2030.
  • Crump C, Paluska SA. Venous thromboembolism following vigorous deep tissue massage. The Physician and Sportsmedicine. 2010;38(4):136-139.
  • Davis MC, Zautra AJ, Wolf LD, et al. Mindfulness and cognitive-behavioral interventions for chronic pain: differential effects on daily pain reactivity and stress reactivity. Journal of Consulting and Clinical Psychology. 2015;83(1):24-35.
  • de los Angeles Pineda M, Thompson SF, Summers K, et al. A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. Medical Science Monitor. 2011;17(6):CR347-CR354.
  • Duffy LC, Sporn S, Hibberd P, et al. Lactobacilli and bifidobacteria. In: Coates PM, Betz JM, Blackman MR, et al., eds. Encyclopedia of Dietary Supplements. 2nd ed. New York, NY: Informa Healthcare; 2010:469-478.
  • Fogarty FA, Booth RJ, Gamble GD, et al. The effect of mindfulness-based stress reduction on disease activity in people with rheumatoid arthritis: a randomised controlled trial. Annals of Rheumatic Diseases. 2015;74(2):472-474.
  • Furst DE, Venkatraman MM, McGann M, et al. Double-blind, randomized, controlled, pilot study comparing classic Ayurvedic medicine, methotrexate, and their combination in rheumatoid arthritis. Journal of Clinical Rheumatology. 2011;17(4):185-192.
  • Gilbey A, Perezgonzalez JD. Health benefits of deer and elk velvet antler supplements: a systematic review of randomised controlled studies. New Zealand Medical Journal. 2012;125(1367):80-86.
  • Gogtay NJ, Bhatt HA, Dalvi SS, et al. The use and safety of non-allopathic Indian medicines. Drug Safety. 2002;25(14):1005-1019.
  • Goldbach-Mansky R, Wilson M, Fleischmann R, et al. Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial. Annals of Internal Medicine. 2009;151(4):229-240.
  • Guo Z, Chen W, Su Y, et al. Isolated unilateral vertebral pedicle fracture caused by a back massage in an elderly patient: a case report and literature review. European Journal of Orthopaedic Surgery and Traumatology. 2013;23 Suppl 2:S149-S153.
  • Haaz S, Bartlett SJ. Yoga for arthritis: a scoping review. Rheumatic Diseases Clinics of North America. 2011;37(1):33-46.
  • Hatakka K, Martio J, Korpela M, et al. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis—a pilot study. Scandinavian Journal of Rheumatology. 2003;32(4):211-215.
  • Hempel S, Newberry S, Ruelaz A, et al. Safety of Probiotics to Reduce Risk and Prevent or Treat Disease. Evidence Report/Technology Assessment no. 200. Rockville, MD: Agency for Healthcare Research and Quality; 2011. AHRQ publication no. 11-E007.
  • Kligler B, Cohrssen A. Probiotics. American Family Physician. 2008;78(9):1073-1078.
  • Lao L. Safety issues in acupuncture. Journal of Alternative and Complementary Medicine. 1996;2(1):27-31.
  • Lee MS, Shin B-C, Ernst E. Acupuncture for rheumatoid arthritis: a systematic review. Rheumatology. 2008;47(12):1747-1753.
  • Lustyk MK, Chawla N, Nolan RS, et al. Mindfulness meditation research: issues of participant screening, safety procedures, and researcher training. Advances in Mind-Body Medicine. 2009;24(1):20-30.
  • Lv Q-W, Zhang W, Shi Q, et al. Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial. Annals of the Rheumatic Diseases. 2015;74(6):1078-1086.
  • Macfarlane GJ, El-Metwally A, De Silva V, et al. Evidence for the efficacy of complementary and alternative medicines in the management of rheumatoid arthritis: a systematic review. Rheumatology. 2011;50(9):1672-1683.
  • Macfarlane GJ, Paudyal P, Doherty M, et al. A systematic review of evidence for the effectiveness of practitioner-based complementary and alternative therapies in the management of rheumatic diseases: rheumatoid arthritis. Rheumatology. 2012;51(9):1707-1713.
  • Mandel DR, Eichas K, Holmes J. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complementary and Alternative Medicine. 2010;10:1.
  • Maste P, Paik SH, Oh JK, et al. Acute spinal subdural hematoma after vigorous back massage: a case report and review of literature. Spine. 2014;39(25):E1545-E1548.
  • Sanders ME, Akkermans LM, Haller D, et al. Safety assessment of probiotics for human use. Gut Microbes. 2010;1(3):164-185.
  • Santos I, Cantista P, Vasconcelos C. Balneotherapy in rheumatoid arthritis—a systematic review. International Journal of Biometeorology. 2016;60(8):1287-1301.
  • Saper RB, Phillips RS, Sehgal A, et al. Lead, mercury, and arsenic in U.S.- and Indian-manufactured Ayurvedic medicines sold via the Internet. JAMA. 2008;300(8):915-923.
  • Setty AR, Sigal LH. Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects. Seminars in Arthritis and Rheumatism. 2005;34(6):773-784.
  • Shanahan F. A commentary on the safety of probiotics. Gastroenterology Clinics of North America. 2012;41(4):869-876.
  • Stack RJ, Shaw K, Mallen C, et al. Delays in help seeking at the onset of the symptoms of rheumatoid arthritis: a systematic synthesis of qualitative literature. Annals of the Rheumatic Diseases. 2012;71(4):493-497.
  • Sun F, Yuan QL, Zhang YG. Large buttocks hematoma caused by deep tissue massage therapy. Pain Medicine. 2015;16(7):1445-1447.
  • Szymanski KM, Wheeler DC, Mucci LA. Fish consumption and prostate cancer risk: a review and meta-analysis. American Journal of Clinical Nutrition. 2010;92(5):1223-1233.
  • Taibi DM, Bourguignon C. The role of complementary and alternative therapies in managing rheumatoid arthritis. Family & Community Health. 2003;26(1):41-52.
  • Verhagen AP, Bierma-Zeinstra SM, Boers M, et al. Balneotherapy (or spa therapy) for rheumatoid arthritis. Cochrane Database of Systematic Reviews. 2015;(4):CD000518. Accessed at http://www.cochranelibrary.com on January 16, 2018.
  • Vickers A, Zollman C, Payne DK. Hypnosis and relaxation therapies. Western Journal of Medicine. 2001;175(4):269-272.
  • Wang C, de Pablo P, Chen X, et al. Acupuncture for pain relief in patients with rheumatoid arthritis: a systematic review. Arthritis and Rheumatism. 2008;59(9):1249-1256.
  • Wang X, Zu Y, Huang L, et al. Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: a meta-analysis. Life Sciences. 2017;171:45-50.
  • Ward L, Treharne GJ, Stebbings S. The suitability of yoga as a potential therapeutic intervention for rheumatoid arthritis: a focus group approach. Musculoskeletal Care. 2011;9(4):211-221.
  • Yin P, Gao N, Wu J, et al. Adverse events of massage therapy in pain-related conditions: a systematic review. Evidence-Based Complementary and Alternative Medicine. 2014;2014:480956.
  • Xu S, Wang L, Cooper E, et al. Adverse events of acupuncture: a systematic review of case reports. Evidence-Based Complementary and Alternative Medicine. 2013;2013:581203.
  • Zamani B, Golkar HR, Farshbaf S, et al. Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. International Journal of Rheumatic Diseases. 2016;19(9):869-879.

Acknowledgments

NCCIH thanks D. Craig Hopp, Ph.D., and David Shurtleff, Ph.D., NCCIH, for their review of the 2019 update of thispublication.

This publication is not copyrighted and is in the public domain. Duplication is encouraged.

NCCIH has provided this material for your information. It is not intended to substitute for the medical expertise and advice of your health care provider(s). We encourage you to discuss any decisions about treatment or care with your health care provider. The mention of any product, service, or therapy is not an endorsement by NCCIH.

FAQs

What are the five signs of rheumatoid arthritis? ›

Five signs of rheumatoid arthritis
  • Stiffness. Waking up refreshed in the morning is the best way to start the day. ...
  • Chronic fatigue. If you've noticed joint stiffness with a decrease in energy, it may be time to give us a call. ...
  • Joint swelling. ...
  • Numbness and tingling. ...
  • Fever.

What is the main cause of rheumatoid arthritis? ›

Rheumatoid arthritis is an autoimmune condition, which means it's caused by the immune system attacking healthy body tissue. However, it's not yet known what triggers this. Your immune system normally makes antibodies that attack bacteria and viruses, helping to fight infection.

How do you explain what rheumatoid arthritis feels like? ›

A person with RA may feel intense pain in their joints during flares. This may feel like sustained pressure, a burning sensation, or a sharp pain. However, people with RA may also experience periods of remission when they feel few to no symptoms. In addition to causing pain in the joints, RA can affect the whole body.

What are the 4 stages of rheumatoid arthritis? ›

The four stages of rheumatoid arthritis are known as synovitis, pannus, fibrous ankylosis, and bony ankylosis.
  • Stage I: Synovitis. During stage I, you may start having mild symptoms, including joint pain and joint stiffness. ...
  • Stage II: Pannus. ...
  • Stage III: Fibrous Ankylosis. ...
  • Stage IV: Bony Ankylosis.
Oct 12, 2021

What are 3 symptoms of rheumatoid arthritis? ›

What are the signs and symptoms of RA?
  • Pain or aching in more than one joint.
  • Stiffness in more than one joint.
  • Tenderness and swelling in more than one joint.
  • The same symptoms on both sides of the body (such as in both hands or both knees)
  • Weight loss.
  • Fever.
  • Fatigue or tiredness.
  • Weakness.

Is RA caused by stress? ›

Rheumatoid arthritis (RA) is a chronic inflammatory joint condition and an autoimmune disease that can be caused by stress, according to research. Stress triggers rheumatoid arthritis by setting off the immune system's inflammatory response in which cytokines are released.

What are the 3 types of rheumatoid arthritis? ›

Types of Rheumatoid Arthritis – Seropositive or Seronegative RA
  • Rheumatoid Factor Positive (Seropositive) RA. ...
  • Rheumatoid Factor Negative (Seronegative) RA. ...
  • Overlapping Conditions.
Feb 11, 2016

What organs can rheumatoid arthritis affect? ›

In rheumatoid arthritis, your immune system attacks healthy tissue in your joints. It can also cause medical problems with your heart, lungs, nerves, eyes and skin.

Where does RA pain start? ›

The most commonly affected areas during the onset of RA are the small joints in your hands and feet. This is where you may first feel stiffness and an ache. It's also possible for RA inflammation to affect your knees and hips.

What are the 7 diagnostic criteria for RA? ›

The new criteria are as follows: 1) morning stiffness in and around joints lasting at least 1 hour before maximal improvement; 2) soft tissue swelling (arthritis) of 3 or more joint areas observed by a physician; 3) swelling (arthritis) of the proximal interphalangeal, metacarpophalangeal, or wrist joints; 4) symmetric ...

How painful is rheumatoid arthritis? ›

If you have RA, joint pain can range from mild to moderate or severe. Sometimes it can feel like a sprain or broken bone. Some areas of your body may even be painful to the touch.

How serious is rheumatoid arthritis? ›

Having rheumatoid arthritis can lead to several other conditions that may cause additional symptoms and can sometimes be life threatening. Possible complications include: carpal tunnel syndrome. inflammation of other areas of the body (such as the lungs, heart and eyes)

What it's like living with rheumatoid arthritis? ›

Rheumatoid arthritis causes joint pain and swelling, reduced mobility and physical weakness. General tiredness, trouble sleeping and exhaustion are other common symptoms. All of these symptoms can greatly affect your everyday life and overall wellbeing. Living with rheumatoid arthritis isn't always easy.

What is a high level of rheumatoid factor? ›

What are the normal ranges for rheumatoid factor? The "normal" range (or negative test result) for rheumatoid factor is less than 14 IU/ml. Any result with values 14 IU/ml or above is considered abnormally high, elevated, or positive.

Why is arthritis pain worse at night? ›

Lying down can cause inflammatory chemicals to pool in the fluid that cushions your joints, which makes them stiffen up. And your perception of pain may be heightened during the nighttime because you're not distracted by anything else.

What is the best medication for rheumatoid arthritis pain? ›

Methotrexate is usually the first medicine given for rheumatoid arthritis, often with another DMARD and a short course of steroids (corticosteroids) to relieve any pain. These may be combined with biological treatments.
...
The DMARDs that may be used include:
  • methotrexate.
  • leflunomide.
  • hydroxychloroquine.
  • sulfasalazine.

How do doctors know if you have rheumatoid arthritis? ›

There is no one blood test or physical finding to confirm the diagnosis. During the physical exam, your doctor will check your joints for swelling, redness and warmth. He or she may also check your reflexes and muscle strength.

Where does rheumatoid arthritis usually start? ›

Early rheumatoid arthritis tends to affect your smaller joints first — particularly the joints that attach your fingers to your hands and your toes to your feet. As the disease progresses, symptoms often spread to the wrists, knees, ankles, elbows, hips and shoulders.

How do I find out if I have rheumatoid arthritis? ›

Your doctor may offer blood tests looking for rheumatoid factor (RF) and/or anti-CCP (anti-cyclic citrullinated peptide) antibodies to diagnose rheumatoid arthritis, even though these tests aren't always definitive. Some people with early-stage RA or other autoimmune diseases may have false positives or negatives.

Can Covid trigger rheumatoid arthritis? ›

Multiple studies have reported autoantibodies in patients with COVID-19, particularly anti-cardiolipin, anti-β2-glycoprotein I and antinuclear antibodies. 1 2 Anti-citrullinated protein antibodies (ACPA) and flaring of rheumatoid arthritis (RA) after SARS-Cov-2 infection have also been described.

How painful is rheumatoid arthritis? ›

If you have RA, joint pain can range from mild to moderate or severe. Sometimes it can feel like a sprain or broken bone. Some areas of your body may even be painful to the touch.

How fast can rheumatoid arthritis progress? ›

Clinical History. The typical case of rheumatoid arthritis begins insidiously, with the slow development of signs and symptoms over weeks to months. Often the patient first notices stiffness in one or more joints, usually accompanied by pain on movement and by tenderness in the joint.

Notably, Prof McInnes highlighted that new and updated EULAR statutes entered into force on 1 January 2021, and to accompany these, EULAR is now the ‘European Alliance of Associations for Rheumatology’.. There does appear to be an increased risk of severe disease and COVID-19-related death associated with glucocorticoid use.. Remote consultations make it more difficult to assess physical disease and pick up on non-verbal cues that reveal a patient’s state of mind, meaning these warning signs may be missed; therefore, it is advised that patients should always be asked about their mental health at every remote consultation.. What is new in fatigue in arthritis and systemic rheumatic diseases?. Data on the treatment and management of fatigue come mainly from studies of people with RA.. Costantino Pitzalis, London, UK, described how characterisation of synovial biopsies from people with RA, using histological and molecular signature analysis, enables their classification into different disease pathotypes, which can be used to predict treatment response and refractoriness.. Elena Nikiphorou, London, UK, highlighted that identification and early targeting of comorbidities is particularly important in D2T RA.. Comorbidities can also reduce the effectiveness of treatment and increase adverse drug reactions, negatively impact on treatment goals, disease outcomes and overall prognosis, and are associated with increased healthcare utilisation and costs versus people without these conditions.. Diego Kyburz, Basel, Switzerland, presented the results of an observational cohort study using data from the Swiss RA registry regarding JAK inhibition in RA, gathered over 10 years of real-life use and including adults with RA who started treatment with tofacitinib (n=793), TNF inhibitors (n=1847) or other mechanism of action bDMARDs (n=1338).. TNF inhibitors showed a significantly lower drug retention rate than tofacitinib (hazard ratio 1.29 [95% CI 1.14, 1.47]; p<0.001), with more patients tending to discontinue TNF inhibitors due to ineffectiveness, and tofacitinib due to a greater intolerance to side effects vs. bDMARDs.. The COVID-19 pandemic has had a substantial impact on working people with RMDs.. ©Springer Healthcare 2021.

Notably, Prof McInnes highlighted that new and updated EULAR statutes entered into force on 1 January 2021, and to accompany these, EULAR is now the ‘European Alliance of Associations for Rheumatology’.. There does appear to be an increased risk of severe disease and COVID-19-related death associated with glucocorticoid use.. Multivariate ordinal logistic regression analyses showed that use of rituximab or JAK inhibitors for RA was associated with a 4-fold or 2-fold increased risk, respectively, of more severe COVID-19 outcomes versus TNF inhibitor use.. Remote consultations make it more difficult to assess physical disease and pick up on non-verbal cues that reveal a patient’s state of mind, meaning these warning signs may be missed; therefore, it is advised that patients should always be asked about their mental health at every remote consultation.. What is new in fatigue in arthritis and systemic rheumatic diseases?. Data on the treatment and management of fatigue come mainly from studies of people with RA.. Costantino Pitzalis, London, UK, described how characterisation of synovial biopsies from people with RA, using histological and molecular signature analysis, enables their classification into different disease pathotypes, which can be used to predict treatment response and refractoriness.. Elena Nikiphorou, London, UK, highlighted that identification and early targeting of comorbidities is particularly important in D2T RA.. Comorbidities can also reduce the effectiveness of treatment and increase adverse drug reactions, negatively impact on treatment goals, disease outcomes and overall prognosis, and are associated with increased healthcare utilisation and costs versus people without these conditions.. The concept of JAK selectivity is based on data from in vitro assays, which have limited ability to translate to, and inform, the cellular and clinical aspects of the use of JAK inhibitors to treat RA.. Diego Kyburz, Basel, Switzerland, presented the results of an observational cohort study using data from the Swiss RA registry regarding JAK inhibition in RA, gathered over 10 years of real-life use and including adults with RA who started treatment with tofacitinib (n=793), TNF inhibitors (n=1847) or other mechanism of action bDMARDs (n=1338).. TNF inhibitors showed a significantly lower drug retention rate than tofacitinib (hazard ratio 1.29 [95% CI 1.14, 1.47]; p<0.001), with more patients tending to discontinue TNF inhibitors due to ineffectiveness, and tofacitinib due to a greater intolerance to side effects vs. bDMARDs.. The COVID-19 pandemic has had a substantial impact on working people with RMDs.. ©Springer Healthcare 2021.

About Arthritis What Is Arthritis?. Healthy Living Microbiome, Gut Health & Arthritis Microbiome, microbes, microorganisms – these terms may be confusing, but the types of bacteria living in and on our bodies can impact arthritis.. Arthritis and Mental Health Learn about the connection between arthritis, depression and anxiety and how these conditions can make your arthritis worse.. JA Camps The Arthritis Foundation’s JA camp programs give kids with arthritis and related childhood rheumatic diseases the chance to make lasting memories.. Conquering Childhood Arthritis The Arthritis Foundation is mobilizing patients and their families to engage in studies comparing the effectiveness of treatments for juvenile arthritis and funding research for more options.. Rheumatoid arthritis (RA) causes joint inflammation and pain.. The doctor will ask about joint symptoms (pain, tenderness, stiffness, difficulty moving), when they started, if they come and go, how severe they are, what actions make them better or worse and whether family members have RA or another autoimmune disease.. Rheumatoid Arthritis People in the United States who have rheumatoid arthritis.. Every gift to the Arthritis Foundation will help people with arthritis across the U.S. live their best life.. Every gift to the Arthritis Foundation will help people with arthritis across the U.S. live their best life.. As a partner, you will help the Arthritis Foundation provide life-changing resources, science, advocacy and community connections for people with arthritis, the nations leading cause of disability.

The Rheumatoid Arthritis Pipeline is robust as various companies such as Ablynx, Cyxone, Oryn Therapeutics, Gilead Sciences, Sorrento Therapeutics, Genor Biopharma, Kang Stem Biotech, Celltex Therapeutics, Bristol-Myers Squibb, Arthrogen, Baylx, R-Pharm, Astellas Pharma, Sanofi, Amgen, I-MAB Biopharma, Taisho Pharmaceutical, Novartis, Kymera Therapeutics, UCB, and many others are developing therapies to influence treatment scenarios.. DelveInsight’s “ Rheumatoid Arthritis Pipeline Insight '' report provides comprehensive insights about 200+ companies and 250+ pipeline drugs in the Rheumatoid Arthritis pipeline landscapes.. It also includes the Rheumatoid Arthritis therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive Rheumatoid Arthritis pipeline products.. Several companies such as Ablynx, Cyxone, Oryn Therapeutics, Gilead Sciences, Sorrento Therapeutics, Genor Biopharma, Kang Stem Biotech, Celltex Therapeutics, Bristol-Myers Squibb, Arthrogen, Baylx, R-Pharm, Astellas Pharma, Sanofi, Amgen, I-MAB Biopharma, Taisho Pharmaceutical, Novartis, Kymera Therapeutics, UCB , and many others are developing therapies for the treatment of Rheumatoid Arthritis.. Get an overview of pipeline landscape @ Rheumatoid Arthritis Clinical Trial Analysis Rheumatoid Arthritis is an autoimmune disease, which causes pain, swelling, and stiffness in the joints and usually affects the hands, feet and wrists.. Results Ablynx announced that its anti-TNFα Nanobody, ozoralizumab (ATN-103), for the treatment of the inflammatory diseases, displayed excellent safety and efficacy results in the 48-week open-label extension (OLE) study of the globally and Japanese Phase II trials in the treatment of patients with Rheumatoid Arthritis who have an insufficient response to methotrexate alone.. Key Drugs Profiles: 250+ Products Phases: Rheumatoid Arthritis Therapies Late-stage (Phase III) Rheumatoid Arthritis Therapies Mid-stage (Phase II) Rheumatoid Arthritis Therapies Early-stage (Phase I) Rheumatoid Arthritis Preclinical stage and Discovery candidates Discontinued and Inactive candidates. How many companies are developing therapies for the treatment of Rheumatoid Arthritis?. How many are Rheumatoid Arthritis emerging therapies in the early-stage, mid-stage, and late stages of development to treat Rheumatoid Arthritis?. 1Rheumatoid Arthritis Report Introduction2Rheumatoid Arthritis Executive Summary3Rheumatoid Arthritis Overview4Rheumatoid Arthritis Analytical Perspective In-depth Commercial Assessment5Rheumatoid Arthritis Pipeline Therapeutics6Rheumatoid Arthritis Late-Stage Products (Phase III)6.1Ozoralizumab: Ablynx7Rheumatoid Arthritis Mid-Stage Products (Phase II)7.1Rabeximod: Cyxone8Rheumatoid Arthritis Early-Stage Products (Phase I)8.1ORTD 1: Oryn Therapeutics9Rheumatoid Arthritis Preclinical Stage Products9.1KT 474: Kymera Therapeutics10Rheumatoid Arthritis Therapeutic Assessment11Rheumatoid Arthritis Inactive Products12Company-University Collaborations (Licensing/Partnering) Rheumatoid Arthritis Analysis 13Rheumatoid Arthritis Key Companies14Rheumatoid Arthritis Key Products15Rheumatoid Arthritis Unmet Needs16 Rheumatoid Arthritis Market Drivers and Barriers17Rheumatoid Arthritis Future Perspectives and Conclusion18Rheumatoid Arthritis Analyst Views19Appendix20About DelveInsight DelveInsight's Rheumatoid Arthritis (RA) - Market Insights, Epidemiology and Market Forecast - 2030 report provides a detailed overview of the disease and an in-depth understanding of the disease, historical, and forecasted epidemiology.. DelveInsight's Rheumatoid Arthritis (RA) - Epidemiology Forecast 2030 report delivers an in-depth understanding of the disease, historical, and forecasted epidemiology of Rheumatoid Arthritis.. DelveInsight's Ocular Hypertension - Market Insights, Epidemiology and Market Forecast - 2030 report provides a detailed overview of the disease and an in-depth understanding of historical and forecasted epidemiology.. DelveInsight's Hairy Cell Leukemia (HCL) - Market Insights, Epidemiology and Market Forecast - 2030 report provides a detailed overview of the disease and an in-depth understanding of historical and forecasted epidemiology.

Your doctor may recommend X-rays to help track the progression of rheumatoid arthritis in your joints over time.. The types of medications recommended by your doctor will depend on the severity of your symptoms and how long you've had rheumatoid arthritis.. These drugs can slow the progression of rheumatoid arthritis and save the joints and other tissues from permanent damage.. If medications fail to prevent or slow joint damage, you and your doctor may consider surgery to repair damaged joints.. Surgery to remove the inflamed lining of the joint (synovium) can help reduce pain and improve the joint's flexibility.. Surgically fusing a joint may be recommended to stabilize or realign a joint and for pain relief when a joint replacement isn't an option.. Some preliminary studies have found that fish oil supplements may reduce rheumatoid arthritis pain and stiffness.. While you might first discuss your symptoms with your family doctor, he or she may refer you to a doctor who specializes in the treatment of arthritis and other inflammatory conditions (rheumatologist) for further evaluation.. Total joint replacement for severe rheumatoid arthritis.

The Rheumatoid Arthritis Diagnostic Tests report shows the top request players from these company biographies, Rheumatoid Arthritis Diagnostic Tests product information, construction shops, and capacity, request share, Rheumatoid Arthritis Diagnostic Tests promote growth and marketing and advertising strategies employed by them.. Indeed though SWOT disquisition of the worldwide Rheumatoid Arthritis Diagnostic Tests request players can help the observers to determine the chances and also to understand competition design of their Rheumatoid Arthritis Diagnostic Tests report.. Then, price analysis of colorful Rheumatoid Arthritis Diagnostic Tests Market crucial players is also covered.. ➡ Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging Rheumatoid Arthritis Diagnostic Tests market. Global Rheumatoid Arthritis Diagnostic Tests Request share analysis of the top assiduity players.. Global Rheumatoid Arthritis Diagnostic Tests Request vaticinations for a minimum of 5 times of all the mentioned parts, sub parts and the indigenous Global Rheumatoid Arthritis Diagnostic Tests requests.. Lyme Disease Diagnostic Testing Market. https://www.qandqmarketresearch.com/report-sample/dermatology-diagnostic-devices-market-6. This report studies the global Dermatology Diagnostic Devices market status and forecast, categorizes the global Dermatology Diagnostic Devices market size value & volume by key players, type, application, and region.. The research study, titled “Cervical Cancer Diagnostic Tests Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020,”…

In this report, we analyze the Rheumatoid Arthritis and Lupus Treatments industry from two aspects.. Who are the global key manufacturers of Rheumatoid Arthritis and Lupus Treatments industry?. What are the types and applications of Rheumatoid Arthritis and Lupus Treatments?. Economic impact on Rheumatoid Arthritis and Lupus Treatments industry and development trend of Rheumatoid Arthritis and Lupus Treatments industry.6.. To provide country level analysis of the market for segment by application, product type and sub-segments.6.

Global Rheumatoid Arthritis Therapeutics Market Industry research report provides Segmentation, Types, Application, Size, Industry Growth, Share, Development Trends, Top Manufacturers (AbbVie, Boehringer Ingelheim, Novartis, Regeneron Pharmaceuticals).. The Global “ Rheumatoid Arthritis Therapeutics Market ” Report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, key trends, market drivers, challenges, standardization, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.. Our report focuses on top manufacturers in global Rheumatoid Arthritis Therapeutics market, with production, price, revenue and market share for each manufacturer, covering:. Market Analysis and Insights: Global Rheumatoid Arthritis Therapeutics MarketThe global Rheumatoid Arthritis Therapeutics market is anticipated to rise at a considerable rate during 2021 to 2027.. Global Rheumatoid Arthritis Therapeutics Market: Scope and Market Size Rheumatoid Arthritis Therapeutics market is segmented by company, region (country), by Type, and by Application.. What are the Rheumatoid Arthritis Therapeutics market opportunities and threats faced by the vendors in the global Rheumatoid Arthritis Therapeutics Industry?. What are the market opportunities, market risk, and market overview of the Rheumatoid Arthritis Therapeutics market?. It provides a detailed analysis of changing market trends, current and future technologies used, and various strategies adopted by leading players of the Global Rheumatoid Arthritis Therapeutics Market Report.. 2 Global Growth Trends 2.1 Global Rheumatoid Arthritis Therapeutics Market Perspective2.2 Rheumatoid Arthritis Therapeutics Growth Trends by Regions2.3 Rheumatoid Arthritis Therapeutics Industry Dynamic. 3 Competition Landscape by Key Players 3.1 Global Top Rheumatoid Arthritis Therapeutics Players by Revenue3.2 Global Rheumatoid Arthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)3.3 Players Covered: Ranking by Rheumatoid Arthritis Therapeutics Revenue3.4 Global Rheumatoid Arthritis Therapeutics Market Concentration Ratio3.5 Rheumatoid Arthritis Therapeutics Key Players Head office and Area Served3.6 Key Players Rheumatoid Arthritis Therapeutics Product Solution and Service3.7 Date of Enter into Rheumatoid Arthritis Therapeutics Market3.8 Mergers and Acquisitions, Expansion Plans. 4 Rheumatoid Arthritis Therapeutics Breakdown Data by Type 4.1 Global Rheumatoid Arthritis Therapeutics Historic Market Size by Type4.2 Global Rheumatoid Arthritis Therapeutics Forecasted Market Size by Type. 5 Rheumatoid Arthritis Therapeutics Breakdown Data by Application 5.1 Global Rheumatoid Arthritis Therapeutics Historic Market Size by Application5.2 Global Rheumatoid Arthritis Therapeutics Forecasted Market Size by Application

The " Rheumatoid Arthritis Stem Cell Therapy market " research report covers the scope, size, and growth of the industry including the key success factors during period from 2022 to 2028.. This Rheumatoid Arthritis Stem Cell Therapy Market Research Report provides a comprehensive analysis of the Rheumatoid Arthritis Stem Cell Therapy market’s revenue and analyzes the market trends based on Region, product type, and end-use.. The market research report provides a detailed overview of market growth enablers, restraints, and trends and also includes a list of key competitors(Mesoblast,Roslin Cells,Regeneus,ReNeuron Group,International Stem Cell Corporation,Takeda).. The Rheumatoid Arthritis Stem Cell Therapy Market Research report helps to dig into market shares by region and sector, product developments and distribution strategies, challenges from the competition, and future prospects.. We have also bifurcated the reports on the industry types as Allogeneic Mesenchymal Stem Cells,Bone Marrow Transplant,Adipose Tissue Stem Cells this classification provides the user the freedom to segment the report based on the industry application as Hospitals,Ambulatory Surgical Centers,Specialty Clinics.. Report Overview Global Growth Trends Competition Landscape by Key Players Data by Type Data by Application North America Market Analysis Europe Market Analysis Asia-Pacific Market Analysis Latin America Market Analysis Middle East & Africa Market Analysis Key Players Profiles Market Analysis Analysts Viewpoints/Conclusions Appendix. The Rheumatoid Arthritis Stem Cell Therapy Market Research Reports report provides a comprehensive analysis of market size with the potential impact of COVID-19.. This Market report covers the impact of demand & supply, pricing variants, and recommendations for Rheumatoid Arthritis Stem Cell Therapy market considering the current update on coronavirus.. Rheumatoid Arthritis Stem Cell Therapy market research report gives the information about the challenges faced by Rheumatoid Arthritis Stem Cell Therapy Industry's demand, supply, price, and quantity, quality of a product or service.. This Rheumatoid Arthritis Stem Cell Therapy Market Research Report provides a comprehensive analysis of the Rheumatoid Arthritis Stem Cell Therapy market’s revenue and analyzes the market trends based on Region, product type, and end-use.. Gives a Holistic View of the Rheumatoid Arthritis Stem Cell Therapy Market Dynamics of the Rheumatoid Arthritis Stem Cell Therapy market.

The global Rheumatoid Arthritis Treatment market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on HNY Research newly published report.. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).. Key Indicators Analysed. Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027.. Opportunities and Drivers: Identifying the Growing Demands and New Technology. Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.. 1 Report Overview. 1.1 Study Scope and Definition. 1.2 Research Methodology. 1.2.1 Methodology/Research Approach. 1.2.2 Data Source. 1.3 Key Market Segments. 1.4 Players Covered: Ranking by Rheumatoid Arthritis Treatment Revenue. 1.5 Market Analysis by Type. 1.5.1 Global Rheumatoid Arthritis Treatment Market Size Growth Rate by Type: 2021 VS 2027. 1.5.2 Symptomatic Treatment. 1.5.3 Intermediate Corticosteroid Therapies. 1.5.4 Disease Modifying Antirheumatic Drug Therapies. 1.6 Market by Application. 1.6.1 Global Rheumatoid Arthritis Treatment Market Share by Application: 2022-2027. 1.6.2 Hospital Pharmacy. 1.6.3 Retail Pharmacy. 1.6.4 Drug Stores. 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth. 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections. 1.7.2 Covid-19 Impact: Commodity Prices Indices. 1.7.3 Covid-19 Impact: Global Major Government Policy. 1.8 Study Objectives. 1.9 Years Considered. 2 Global Rheumatoid Arthritis Treatment Market Trends and Growth Strategy. 2.1 Market Top Trends. 2.2 Market Drivers. 2.3 Market Challenges. 2.4 Porter’s Five Forces Analysis. 2.5 Market Growth Strategy. 2.6 SWOT Analysis. 3 Global Rheumatoid Arthritis Treatment Market Players Profiles. 3.1 Sanofi. 3.1.1 Sanofi Company Profile. 3.1.2 Sanofi Rheumatoid Arthritis Treatment Product Specification. 3.1.3 Sanofi Rheumatoid Arthritis Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021). 3.2 Pfizer. 3.2.1 Pfizer Company Profile. 3.2.2 Pfizer Rheumatoid Arthritis Treatment Product Specification. 3.2.3 Pfizer Rheumatoid Arthritis Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021). 3.3 Roche. 3.3.1 Roche Company Profile. 3.3.2 Roche Rheumatoid Arthritis Treatment Product Specification. 3.3.3 Roche Rheumatoid Arthritis Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021). 3.4 Johnson & Johnson. 3.4.1 Johnson & Johnson Company Profile. 3.4.2 Johnson & Johnson Rheumatoid Arthritis Treatment Product Specification. 3.4.3 Johnson & Johnson Rheumatoid Arthritis Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021). 3.5 AbbVie. 3.5.1 AbbVie Company Profile. 3.5.2 AbbVie Rheumatoid Arthritis Treatment Product Specification. 3.5.3 AbbVie Rheumatoid Arthritis Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021). 3.6 Eli Lilly. 3.6.1 Eli Lilly Company Profile. 3.6.2 Eli Lilly Rheumatoid Arthritis Treatment Product Specification. 3.6.3 Eli Lilly Rheumatoid Arthritis Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021). 3.7 Amgen. 3.7.1 Amgen Company Profile. 3.7.2 Amgen Rheumatoid Arthritis Treatment Product Specification. 3.7.3 Amgen Rheumatoid Arthritis Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021). 3.8 Sobi. 3.8.1 Sobi Company Profile. 3.8.2 Sobi Rheumatoid Arthritis Treatment Product Specification. 3.8.3 Sobi Rheumatoid Arthritis Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021). 3.9 Bristol-Myers Squibb. 3.9.1 Bristol-Myers Squibb Company Profile. 3.9.2 Bristol-Myers Squibb Rheumatoid Arthritis Treatment Product Specification. 3.9.3 Bristol-Myers Squibb Rheumatoid Arthritis Treatment Production Capacity, Revenue, Price and Gross Margin (2016-2021). 4 Global Rheumatoid Arthritis Treatment Market Competition by Market Players. 4.1 Global Rheumatoid Arthritis Treatment Production Capacity Market Share by Market Players (2016-2021). 4.2 Global Rheumatoid Arthritis Treatment Revenue Market Share by Market Players (2016-2021). 4.3 Global Rheumatoid Arthritis Treatment Average Price by Market Players (2016-2021). 5 Global Rheumatoid Arthritis Treatment Production by Regions (2016-2021). 5.1 North America. 5.1.1 North America Rheumatoid Arthritis Treatment Market Size (2016-2021). 5.1.2 Rheumatoid Arthritis Treatment Key Players in North America (2016-2021). 5.1.3 North America Rheumatoid Arthritis Treatment Market Size by Type (2016-2021). 5.1.4 North America Rheumatoid Arthritis Treatment Market Size by Application (2016-2021). 5.2 East Asia. 5.2.1 East Asia Rheumatoid Arthritis Treatment Market Size (2016-2021). 5.2.2 Rheumatoid Arthritis Treatment Key Players in East Asia (2016-2021). 5.2.3 East Asia Rheumatoid Arthritis Treatment Market Size by Type (2016-2021). 5.2.4 East Asia Rheumatoid Arthritis Treatment Market Size by Application (2016-2021). 5.3 Europe. 5.3.1 Europe Rheumatoid Arthritis Treatment Market Size (2016-2021). 5.3.2 Rheumatoid Arthritis Treatment Key Players in Europe (2016-2021). 5.3.3 Europe Rheumatoid Arthritis Treatment Market Size by Type (2016-2021). 5.3.4 Europe Rheumatoid Arthritis Treatment Market Size by Application (2016-2021). 5.4 South Asia. 5.4.1 South Asia Rheumatoid Arthritis Treatment Market Size (2016-2021). 5.4.2 Rheumatoid Arthritis Treatment Key Players in South Asia (2016-2021). 5.4.3 South Asia Rheumatoid Arthritis Treatment Market Size by Type (2016-2021). 5.4.4 South Asia Rheumatoid Arthritis Treatment Market Size by Application (2016-2021). 5.5 Southeast Asia. 5.5.1 Southeast Asia Rheumatoid Arthritis Treatment Market Size (2016-2021). 5.5.2 Rheumatoid Arthritis Treatment Key Players in Southeast Asia (2016-2021). 5.5.3 Southeast Asia Rheumatoid Arthritis Treatment Market Size by Type (2016-2021). 5.5.4 Southeast Asia Rheumatoid Arthritis Treatment Market Size by Application (2016-2021). 5.6 Middle East. 5.6.1 Middle East Rheumatoid Arthritis Treatment Market Size (2016-2021). 5.6.2 Rheumatoid Arthritis Treatment Key Players in Middle East (2016-2021). 5.6.3 Middle East Rheumatoid Arthritis Treatment Market Size by Type (2016-2021). 5.6.4 Middle East Rheumatoid Arthritis Treatment Market Size by Application (2016-2021). 5.7 Africa. 5.7.1 Africa Rheumatoid Arthritis Treatment Market Size (2016-2021). 5.7.2 Rheumatoid Arthritis Treatment Key Players in Africa (2016-2021). 5.7.3 Africa Rheumatoid Arthritis Treatment Market Size by Type (2016-2021). 5.7.4 Africa Rheumatoid Arthritis Treatment Market Size by Application (2016-2021). 5.8 Oceania. 5.8.1 Oceania Rheumatoid Arthritis Treatment Market Size (2016-2021). 5.8.2 Rheumatoid Arthritis Treatment Key Players in Oceania (2016-2021). 5.8.3 Oceania Rheumatoid Arthritis Treatment Market Size by Type (2016-2021). 5.8.4 Oceania Rheumatoid Arthritis Treatment Market Size by Application (2016-2021). 5.9 South America. 5.9.1 South America Rheumatoid Arthritis Treatment Market Size (2016-2021). 5.9.2 Rheumatoid Arthritis Treatment Key Players in South America (2016-2021). 5.9.3 South America Rheumatoid Arthritis Treatment Market Size by Type (2016-2021). 5.9.4 South America Rheumatoid Arthritis Treatment Market Size by Application (2016-2021). 5.10 Rest of the World. 5.10.1 Rest of the World Rheumatoid Arthritis Treatment Market Size (2016-2021). 5.10.2 Rheumatoid Arthritis Treatment Key Players in Rest of the World (2016-2021). 5.10.3 Rest of the World Rheumatoid Arthritis Treatment Market Size by Type (2016-2021). 5.10.4 Rest of the World Rheumatoid Arthritis Treatment Market Size by Application (2016-2021). 6 Global Rheumatoid Arthritis Treatment Consumption by Region (2016-2021). 6.1 North America. 6.1.1 North America Rheumatoid Arthritis Treatment Consumption by Countries. 6.1.2 United States. 6.1.3 Canada. 6.1.4 Mexico. 6.2 East Asia. 6.2.1 East Asia Rheumatoid Arthritis Treatment Consumption by Countries. 6.2.2 China. 6.2.3 Japan. 6.2.4 South Korea. 6.3 Europe. 6.3.1 Europe Rheumatoid Arthritis Treatment Consumption by Countries. 6.3.2 Germany. 6.3.3 United Kingdom. 6.3.4 France. 6.3.5 Italy. 6.3.6 Russia. 6.3.7 Spain. 6.3.8 Netherlands. 6.3.9 Switzerland. 6.3.10 Poland. 6.4 South Asia. 6.4.1 South Asia Rheumatoid Arthritis Treatment Consumption by Countries. 6.4.2 India. 6.5 Southeast Asia. 6.5.1 Southeast Asia Rheumatoid Arthritis Treatment Consumption by Countries. 6.5.2 Indonesia. 6.5.3 Thailand. 6.5.4 Singapore. 6.5.5 Malaysia. 6.5.6 Philippines. 6.6 Middle East. 6.6.1 Middle East Rheumatoid Arthritis Treatment Consumption by Countries. 6.6.2 Turkey. 6.6.3 Saudi Arabia. 6.6.4 Iran. 6.6.5 United Arab Emirates. 6.7 Africa. 6.7.1 Africa Rheumatoid Arthritis Treatment Consumption by Countries. 6.7.2 Nigeria. 6.7.3 South Africa. 6.8 Oceania. 6.8.1 Oceania Rheumatoid Arthritis Treatment Consumption by Countries. 6.8.2 Australia. 6.9 South America. 6.9.1 South America Rheumatoid Arthritis Treatment Consumption by Countries. 6.9.2 Brazil. 6.9.3 Argentina. 6.10 Rest of the World. 6.10.1 Rest of the World Rheumatoid Arthritis Treatment Consumption by Countries. 7 Global Rheumatoid Arthritis Treatment Production Forecast by Regions (2022-2027). 7.1 Global Forecasted Production of Rheumatoid Arthritis Treatment (2022-2027). 7.2 Global Forecasted Revenue of Rheumatoid Arthritis Treatment (2022-2027). 7.3 Global Forecasted Price of Rheumatoid Arthritis Treatment (2022-2027). 7.4 Global Forecasted Production of Rheumatoid Arthritis Treatment by Region (2022-2027). 7.4.1 North America Rheumatoid Arthritis Treatment Production, Revenue Forecast (2022-2027). 7.4.2 East Asia Rheumatoid Arthritis Treatment Production, Revenue Forecast (2022-2027). 7.4.3 Europe Rheumatoid Arthritis Treatment Production, Revenue Forecast (2022-2027). 7.4.4 South Asia Rheumatoid Arthritis Treatment Production, Revenue Forecast (2022-2027). 7.4.5 Southeast Asia Rheumatoid Arthritis Treatment Production, Revenue Forecast (2022-2027). 7.4.6 Middle East Rheumatoid Arthritis Treatment Production, Revenue Forecast (2022-2027). 7.4.7 Africa Rheumatoid Arthritis Treatment Production, Revenue Forecast (2022-2027). 7.4.8 Oceania Rheumatoid Arthritis Treatment Production, Revenue Forecast (2022-2027). 7.4.9 South America Rheumatoid Arthritis Treatment Production, Revenue Forecast (2022-2027). 7.4.10 Rest of the World Rheumatoid Arthritis Treatment Production, Revenue Forecast (2022-2027). 7.5 Forecast by Type and by Application (2022-2027). 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027). 7.5.2 Global Forecasted Consumption of Rheumatoid Arthritis Treatment by Application (2022-2027). 8 Global Rheumatoid Arthritis Treatment Consumption Forecast by Regions (2022-2027). 8.1 North America Forecasted Consumption of Rheumatoid Arthritis Treatment by Country. 8.2 East Asia Market Forecasted Consumption of Rheumatoid Arthritis Treatment by Country. 8.3 Europe Market Forecasted Consumption of Rheumatoid Arthritis Treatment by Countriy. 8.4 South Asia Forecasted Consumption of Rheumatoid Arthritis Treatment by Country. 8.5 Southeast Asia Forecasted Consumption of Rheumatoid Arthritis Treatment by Country. 8.6 Middle East Forecasted Consumption of Rheumatoid Arthritis Treatment by Country. 8.7 Africa Forecasted Consumption of Rheumatoid Arthritis Treatment by Country. 8.8 Oceania Forecasted Consumption of Rheumatoid Arthritis Treatment by Country. 8.9 South America Forecasted Consumption of Rheumatoid Arthritis Treatment by Country. 8.10 Rest of the world Forecasted Consumption of Rheumatoid Arthritis Treatment by Country. 9 Global Rheumatoid Arthritis Treatment Sales by Type (2016-2027). 9.1 Global Rheumatoid Arthritis Treatment Historic Market Size by Type (2016-2021). 9.2 Global Rheumatoid Arthritis Treatment Forecasted Market Size by Type (2022-2027). 10 Global Rheumatoid Arthritis Treatment Consumption by Application (2016-2027). 10.1 Global Rheumatoid Arthritis Treatment Historic Market Size by Application (2016-2021). 10.2 Global Rheumatoid Arthritis Treatment Forecasted Market Size by Application (2022-2027). 11 Global Rheumatoid Arthritis Treatment Manufacturing Cost Analysis. 11.1 Rheumatoid Arthritis Treatment Key Raw Materials Analysis. 11.1.1 Key Raw Materials. 11.2 Proportion of Manufacturing Cost Structure. 11.3 Manufacturing Process Analysis of Rheumatoid Arthritis Treatment. 12 Global Rheumatoid Arthritis Treatment Marketing Channel, Distributors, Customers and Supply Chain. 12.1 Marketing Channel. 12.2 Rheumatoid Arthritis Treatment Distributors List. 12.3 Rheumatoid Arthritis Treatment Customers. 12.4 Rheumatoid Arthritis Treatment Supply Chain Analysis. 13 Analyst's Viewpoints/Conclusions. 14 Disclaimer

It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type.. RA affects joints on both sides of the body, such as both hands, both wrists, and both knees.. Rheumatoid arthritis is diagnosed from a combination of things, including: The location and symmetry of painful joints, especially the hand joints, Joint stiffness in the morning, Bumps and nodules under the skin (rheumatoid nodules) and Results of X-rays and blood tests.. In the report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Rheumatoid Arthritis collaborations, licensing, mergers and acquisition, funding, designations and other product related details.. How many companies are developing Rheumatoid Arthritis drugs?. How many Rheumatoid Arthritis drugs are developed by each company?. Ozoralizumab : Taisho Pharmaceutical

Videos

1. Rheumatoid arthritis - Pathogenesis in detail
(Simon R. Downes - Med School Radio)
2. My Rheumatoid Arthritis (RA) Story
(Swavy Curly Courtney)
3. Overview of Rheumatoid arthritis and treatment : Pharmacology
(Dr.G Bhanu Prakash Animated Medical Videos)
4. How is Rheumatoid Arthritis Diagnosed? | Johns Hopkins Rheumatology
(Johns Hopkins Rheumatology)
5. Rheumatoid Arthritis - Treatment | Johns Hopkins
(Johns Hopkins Rheumatology)
6. Rheumatoid arthritis patients more likely to suffer deadly blood clot - In Depth
(insidermedicine)

You might also like

Latest Posts

Article information

Author: Amb. Frankie Simonis

Last Updated: 08/07/2022

Views: 6228

Rating: 4.6 / 5 (76 voted)

Reviews: 91% of readers found this page helpful

Author information

Name: Amb. Frankie Simonis

Birthday: 1998-02-19

Address: 64841 Delmar Isle, North Wiley, OR 74073

Phone: +17844167847676

Job: Forward IT Agent

Hobby: LARPing, Kitesurfing, Sewing, Digital arts, Sand art, Gardening, Dance

Introduction: My name is Amb. Frankie Simonis, I am a hilarious, enchanting, energetic, cooperative, innocent, cute, joyous person who loves writing and wants to share my knowledge and understanding with you.